We are live on ! Find out more
FCP

Fidelis Capital Partners Portfolio holdings

AUM $1.4B
1-Year Est. Return 31.16%
This Fund
S&P 500
This Quarter Est. Return
+5.76%
1 Year Est. Return
+31.16%
3 Year Est. Return
+98.29%
5 Year Est. Return
10 Year Est. Return
AUM
$840M
AUM Growth
+$137M
Cap. Flow
+$16.6M
Cap. Flow %
1.98%
Top 10 Hldgs %
34.26%
Holding
430
New
52
Increased
220
Reduced
110
Closed
18

Top Sells

Rank Stock Value
1
AVGO icon
Broadcom
AVGO
+$63M
2
V icon
Visa
V
+$921K
3
LLY icon
Eli Lilly
LLY
+$763K
4
BP icon
BP
BP
+$675K
5
CVS icon
CVS Health
CVS
+$652K

Sector Composition

Rank Sector Weight
1 Technology 22.64%
2 Financials 7.56%
3 Consumer Discretionary 6.51%
4 Healthcare 6.29%
5 Communication Services 5.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VTV icon
251
Vanguard Morningstar Value ETF
VTV
$192B
$452K 0.05%
2,576
+828
+47% +$139K
MPC icon
252
Marathon Petroleum
MPC
$83.7B
$451K 0.05%
2,932
-143
-5% -$24.2K
HEI.A icon
253
HEICO Corp Class A
HEI.A
$37.2B
$448K 0.05%
2,260
-55
-2% -$10.4K
MUB icon
254
iShares National Muni Bond ETF
MUB
$45.9B
$444K 0.05%
+4,167
New +$449K
SCHC icon
255
Schwab International Small-Cap Equity ETF
SCHC
$5.65B
$444K 0.05%
+12,020
New +$443K
LHX icon
256
L3Harris
LHX
$53.4B
$433K 0.05%
1,761
-84
-5% -$19.4K
PWR icon
257
Quanta Services
PWR
$101B
$430K 0.05%
1,401
-100
-7% -$26.4K
BN icon
258
Brookfield
BN
$108B
$427K 0.05%
11,847
-536
-4% -$16.9K
FPX icon
259
First Trust US Equity Opportunities ETF
FPX
$1.49B
$422K 0.05%
+4,620
New +$470K
VRSK icon
260
Verisk Analytics
VRSK
$25B
$422K 0.05%
1,582
-71
-4% -$19.2K
SCHW
261
Charles Schwab
SCHW
$187B
$419K 0.05%
5,837
-506
-8% -$33.2K
CSGP icon
262
CoStar Group
CSGP
$12.3B
$418K 0.05%
5,738
-300
-5% -$22.8K
VBR icon
263
Vanguard Morningstar Small-Cap Value ETF
VBR
$38.1B
$417K 0.05%
2,085
+210
+11% +$40.4K
CVS icon
264
CVS Health
CVS
$122B
$414K 0.05%
7,286
-11,181
-61% -$652K
PYPL icon
265
PayPal
PYPL
$50.5B
$413K 0.05%
5,107
+295
+6% +$19.7K
SUB icon
266
iShares Short-Term National Muni Bond ETF
SUB
$11.4B
$412K 0.05%
+3,909
New +$412K
TSM icon
267
TSMC
TSM
$2.18T
$412K 0.05%
2,052
-11
-0.5% -$1.87K
TT icon
268
Trane Technologies
TT
$106B
$406K 0.05%
1,025
+45
+5% +$15.6K
MCHP icon
269
Microchip Technology
MCHP
$46B
$399K 0.05%
5,301
-337
-6% -$27.8K
IDXX icon
270
Idexx Laboratories
IDXX
$46.2B
$397K 0.05%
866
-22
-2% -$10.7K
BX icon
271
Blackstone
BX
$110B
$396K 0.05%
2,374
+62
+3% +$8.6K
MPLX icon
272
MPLX
MPLX
$59.7B
$396K 0.05%
9,032
+338
+4% +$14.4K
LEN icon
273
Lennar Class A
LEN
$21.2B
$393K 0.05%
2,352
-243
-9% -$40.7K
GILD icon
274
Gilead Sciences
GILD
$165B
$392K 0.05%
4,494
+268
+6% +$20.4K
LYV icon
275
Live Nation Entertainment
LYV
$42.1B
$388K 0.05%
3,385
+23
+0.7% +$2.22K

Similar funds

Fidelis Capital Partners's Q3 2024 Portfolio in Review

As of Q3 2024, Fidelis Capital Partners held 430 positions worth $840M, up 20% from $702M the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Fidelis Capital Partners's Q3 2024 filing shows 52 new, 220 increased, 110 reduced and 18 closed positions. Its largest new stake was iShares Russell Top 200 Growth ETF: 20,493 shares worth $4.54M. The largest sale was Broadcom, an estimated $63M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Fidelis Capital Partners's largest Q3 2024 buy was iShares Russell Top 200 Growth ETF: 20,493 shares worth $4.54M.
  • Fidelis Capital Partners added most to Lam Research in Q3 2024, an estimated $10.2M increase.
  • Fidelis Capital Partners's biggest Q3 2024 reduction was Broadcom, cutting an estimated $63M.
  • Fidelis Capital Partners fully exited Valaris in Q3 2024, selling an estimated $637K.
  • Fidelis Capital Partners's ten largest holdings make up 34% of its $840M portfolio in Q3 2024.
  • Fidelis Capital Partners opened 52 new positions and closed 18 in Q3 2024.
  • Fidelis Capital Partners's portfolio value rose 20% quarter-over-quarter to $840M.

Based on Fidelis Capital Partners's 13F filing for Q3 2024, filed 25 Oct 2024.